Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

VYNE Therapeutics Doses First Volunteers In Phase 1a Trial Of VYN202; Oral BET Inhibitor Targeting Immuno-Inflammatory Diseases; Top-Line Data Expected In H2 2024

Author: Benzinga Newsdesk | June 13, 2024 09:04am

Posted In: VYNE